Suppr超能文献

血清 EGF 水平升高而 SDF-1 水平不变与广泛性焦虑障碍的病理生理学和发展有关。

Increased serum EGF but not SDF-1 levels are associated with the pathophysiology and development of generalized anxiety disorder.

机构信息

Department of Pharmacy, University of Asia Pacific, 74/A Green Road, Farmgate, Dhaka, 1205, Bangladesh.

Department of Psychiatry, Bangabandhu Sheikh Mujib Medical University, Shahabagh, Dhaka, 1000, Bangladesh.

出版信息

Sci Rep. 2024 Nov 9;14(1):27409. doi: 10.1038/s41598-024-79166-9.

Abstract

Generalized anxiety disorder (GAD) is a common and persistent mental illness accompanied by uncontrollable worries for daily staff. Physiological, environmental, genetic, and daily stress from surroundings is involved in developing GAD. Here, we aimed to assess the association of stromal cell-derived factor-1 (SDF-1) and epidermal growth factor (EGF) in the pathophysiology of GAD and their role as diagnostic tools. This case-control study recruited 50 GAD patients from the psychiatry department of a tertiary care teaching hospital in Dhaka city and 38 age-sex-matched healthy controls (HCs) from the surrounding areas. A qualified psychiatrist conducted standardized psychiatric interview to diagnose GAD patients and evaluate HCs by applying the diagnostic and statistical manual for mental disorders, 5th edition (DSM-5) and used the GAD-7 scale to assess the severity of the GAD symptoms. After confirming the inclusion and exclusion criteria, we collected 5 ml blood samples from each participant. We measured serum SDF-1 and EGF levels using ELISA techniques. We observed increased serum levels of EGF in GAD patients compared to HCs (5.91 ± 3.90 ng/ml vs. 1.59 ± 1.08 ng/ml; p < 0.001). Also, this increment is positively associated with the severity of GAD in patients (r = 0.479, p = 0.002). The receiver operating characteristic analysis showed good diagnostic performance (AUC 0.869, p < 0.001) with high sensitivity (82.5%), and specificity (81.1%) at cut off value of 2.31 ng/ml. However, we didn't find significant differences in serum SDF-1 levels between GAD patients and HCs (11.96 ± 4.50 ng/ml vs. 12.70 ± 11.76 ng/ml; p = 0.337). The present study suggests that GAD patients have increased serum EGF levels but not SDF-1 levels compared to HCs and that increased EGF levels are associated with increased GAD symptoms as well. Moreover, EGF levels could serve as a biomarker for GAD However, further interventional studies with larger and homogeneous samples are suggested to confirm and establish these findings.

摘要

广泛性焦虑障碍(GAD)是一种常见且持续存在的精神疾病,其特征是患者对日常事务无法控制地担忧。生理、环境、遗传和周围环境的日常压力都与 GAD 的发生有关。在这里,我们旨在评估基质细胞衍生因子-1(SDF-1)和表皮生长因子(EGF)在 GAD 病理生理学中的相关性及其作为诊断工具的作用。这项病例对照研究招募了来自达卡市一家三级教学医院精神科的 50 名 GAD 患者和来自周围地区的 38 名年龄、性别匹配的健康对照者(HCs)。一名合格的精神科医生通过应用精神障碍诊断和统计手册,第五版(DSM-5)对 GAD 患者进行标准化的精神病学访谈,并使用 GAD-7 量表评估 GAD 患者的症状严重程度。在确认纳入和排除标准后,我们从每位参与者中采集 5ml 血样。我们使用 ELISA 技术测量血清 SDF-1 和 EGF 水平。我们观察到 GAD 患者的血清 EGF 水平高于 HCs(5.91±3.90ng/ml 比 1.59±1.08ng/ml;p<0.001)。此外,这种增加与患者 GAD 严重程度呈正相关(r=0.479,p=0.002)。受试者工作特征分析显示,在截断值为 2.31ng/ml 时,具有良好的诊断性能(AUC 0.869,p<0.001),具有高灵敏度(82.5%)和特异性(81.1%)。然而,我们没有发现 GAD 患者和 HCs 之间血清 SDF-1 水平的显著差异(11.96±4.50ng/ml 比 12.70±11.76ng/ml;p=0.337)。本研究表明,与 HCs 相比,GAD 患者的血清 EGF 水平升高,但 SDF-1 水平没有升高,并且 EGF 水平升高与 GAD 症状的加重有关。此外,EGF 水平可能作为 GAD 的生物标志物。然而,建议进行更大规模和更同质样本的干预性研究以确认和建立这些发现。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/24c4/11550425/a610bf546f0d/41598_2024_79166_Fig1_HTML.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验